Summit Medical Group and the MD Anderson Cancer Center collaboration will provide NJ patients with ambulatory cancer care close to home at a lower cost than most local hospitals, says CEO.
Summit Medical Group, the largest privately held multispecialty medical practice in New Jersey, last spring partnered with University of Texas MD Anderson Cancer Center to deliver comprehensive multidisciplinary, ambulatory cancer care at a lower patient cost.
Jeffrey Le Benger, MD, CEO of the new Summit Medical Group MD Anderson Cancer Center, discussed his experience with the new model and how it might apply to similar organizations.
HealthLeaders Media: How and when did your partnership with MD Anderson Cancer Center come about?
Jeffrey Le Benger, MD: Previously, we had good cancer care at [Summit Medical Group], but we didn't have the full spectrum of care. We did some clinical trials, but care was fractured for the community.
So about three years ago, we decided to look for a partner in cancer care that would give us the attributes we were looking for—especially the ability to provide seamless care for patients—and decided to partner with MD Anderson because they were very inclusive.
HLM: Without naming the institutions you didn't pick, what were the qualities you wanted to go after or avoid?
Le Benger: In discussions with other practices in the New York City area, it seemed almost as if they looked at us as a resource for them to get cancer patients to move into the mothership in NYC and then send them back to us for post-care of cancer.
MD Anderson, on the other hand, would expose us to all of its clinical history and expertise in taking care of cancer patients by credentialing our physicians to treat patients at our site. Now we not only have all of the clinical pathways that MD Anderson has, but we also have access to their research, clinical trials, and tumor boards.
Debra Shute is the Senior Physicians Editor for HealthLeaders Media.